Polycystic Ovary (Stein-Leventhal) Syndrome: Etiology, Complications, and Treatment
Explore this paper's citation graph
Summary
Treatment for polycystic ovary syndrome should focus on restoring menstrual regularity, decreasing androgen excesses, and decreasing insulin resistance.
- Type
- article
- Published
- 2004-07-01
- Cited by
- 23
- References
- 44
- OpenAlex
- https://openalex.org/W119049285
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:25644658
Keywords
Hyperandrogenism, Polycystic ovary, Medicine, Infertility, Insulin resistance
References
- Hirsutism and virilization.
- Polycystic ovary syndrome. A diagnostic challenge.
- Can metformin reduce insulin resistance in polycystic ovary syndrome?
- Endometrial Hyperplasia in Young Women
- Polycystic ovary syndrome: it's not just infertility.
- The Female Reproductive System
- Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.
- Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.
- The Merck Manual of Diagnosis and Therapy
- Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study.
- Transvaginal Ultrasound Appearances of the Ovary in Normal Women and Hirsute Women with Oligomenorrhoea
- Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
- Insulin action in the polycystic ovary syndrome.
- Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women.
- Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome.
- Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.
- Insulin-lowering drugs in polycystic ovary syndrome.
- Mortality of women with polycystic ovary syndrome at long-term follow-up.
- Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.
- Ovarian and adrenal function in polycystic ovary syndrome.
Cited by
- Update on the management of polycystic ovary syndrome.
- Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers
- Preoperative luteinizing hormone levels predict the ovulatory response to laparoscopic ovarian drilling in patients with clomiphene citrate-resistant polycystic ovary syndrome
- Polycystic ovary syndrome: a dermatologic approach.
- Unilateral sectioning of the superior ovarian nerve of rats with polycystic ovarian syndrome restores ovulation in the innervated ovary
- Unilateral or bilateral vagotomy induces ovulation in both ovaries of rats with polycystic ovarian syndrome
- Evaluation of Biochemical Hyperandrogenemia and Body Mass Index in Women Presenting with Amenorrhea
- Polycystic Ovary Syndrome (PCOS) and Fertility
- HER LIFESTYLE: a mneumonic for addressing polycystic ovary syndrome in adolescents.
- POLYCYSTIC OVARY SYNDROME
- THE EVOLUTION OF PREGNANCIES FOR THE PATIENTS WITH POLYCYSTIC OVARY SYNDROME AND OVARIAN HYPER STIMULATION SYNDROME
- Menopause in women with polycystic ovary syndrome
- Bearding, Balding and Infertile: Polycystic Ovary Syndrome (PCOS) and Nationalist Discourse in India
- Impact of yoga and exercises on polycystic ovarian syndrome risk among adolescent schoolgirls in South India
- MicroRNA-21 regulate the cell apoptosis and cell proliferation of polycystic ovary syndrome (PCOS) granulosa cells through target toll like receptor TLR8
- Consumption of soya isoflavones improved polycystic ovary syndrome-associated metabolic disorders in a rat model
- Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding
- ASHA: Machine Learning-Based Polycystic Ovary Syndrome (PCOS) Detection and Prediction System
- Title of study: Genotypic and metabolic implications of tumor necrosis factor-α (TNF-α) −1031 (T/C) polymorphism in Kashmiri women with polycystic ovary syndrome (PCOS): a case–control study
- Prevalence of Clinical and Paraclinical Symptoms and Findings in Patients with Polycystic Ovary Syndrome in Ultrasound and Their Fertility Outcomes
Related papers
- Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome.
- The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.
- Ovarian responses to hCG stimulation: insulin resistance/hyperinsulinaemia vs. insulin deficiency
- Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome
- Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
- Polycystic ovary syndrome and hyperandrogenism as a risk factor for cardiovascular disease.
- Adipocyte insulin action in hypogonadotrophic hypogonadism.
- Effect of Metformin Treatment on Insulin Resistance Markers, and Circulating Irisin in Women with Polycystic Ovarian Syndrome (PCOS)
- The Insulin Sensitizing Effects of Electro-acupuncture on Polycystic Ovary Syndrome Rat Models